Directed by the Lupin III trilogy’s Takeshi Koike and penned by Lupin Part IV’s Yuya Takahashi, Lupin the IIIrd: The Movie is the animated equivalent of a meticulously planned heist ...

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease.

Introduced in FY23, Lupin Digital Health marked the company’s foray into the fast-growing digital therapeutics space. Its Lyfe platform focuses on real-time monitoring of patients and offers ...

Mumbai: Indian generics drug maker, Lupin wholly owned diagnostic arm Lupin Diagnostics Limited (LDL) has obtained NABL (National Accreditation Board for Testing and Calibration Laboratories ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for tolvaptan ...

Lupin gets US FDA approval for Tolvaptan tablets. Tolvaptan tablets to be produced at Nagpur facility. Market exclusivity granted for 180 days in the US. Lupin Limited on Thursday said it received ...

Lupin Diagnostics, a wholly owned subsidiary of global pharma major Lupin Limited (Lupin), has achieved 100 per cent NABL (National Accreditation Board for Testing and Calibration Laboratories) ...

Global access to tuberculosis (TB) medicine pretomanid received a shot in the arm, as its price saw a 25 per cent drop, thanks to a third licensed partner, Mumbai-based drugmaker Lupin.

Mumbai (Maharashtra) [India], April 22: In a groundbreaking achievement, Lupin Limited has set a new benchmark in Real-World Evidence (RWE) research by successfully onboarding 67,802 diabetes ...

Generic drugmaker Lupin has received U.S. Food and Drug Administration approval for Tolvaptan tablets of different strengths. It is the exclusive first-to-file for this product and consequently ...

Lupin, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹2101.75. The stock has experienced fluctuations today, with a low of ...

“We are positive on these three stocks—Sun Pharma, Dr Reddy’s, and Lupin—despite the tariff announcements. India remains the ‘pharmacy of the world,’ and there’s no challenge to its ...